Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Panther Life Sciences Opens Next-Generation Microarray Patch (MAP) Platform to Pharma and Biotech Partners for Co-Development of Advanced Therapies

    Jan 7, 2026, 09:18 AM by
    Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its next-generation MAP platform, ahead of the 2026 JPMorgan Healthcare Conference.
    Full story
  • Systems Biology Map for Advancing the Translation of Extracellular Vesicles

    Jan 7, 2026, 01:01 AM by User Not Found
    Bio-IT World | Extracellular vesicles (EVs) are the master communicators of multicellular life, key in orchestrating the complex signaling networks that define physiology. A new multiomics study has now revealed their molecular cargo via EVMap, a high-resolution blueprint of the proteins and lipids in human circulating EVs providing a practical pathway forward across basic, translational and clinical applications.
    Full story
  • Insilico Medicine’s IPO, Servier Pharma Deal

    Jan 6, 2026, 14:17 PM by User Not Found
    Bio-IT World | On December 30, Insilico Medicine successfully listed on the Hong Kong Stock Exchange. This initial public offering (IPO) raised a total of HKD 2.277 billion ($292 billion), achieving the largest biotech IPO in Hong Kong in 2025.
    Full story
  • TeleTracking Appoints Derek Ritchea as Chief Strategy Officer

    Jan 6, 2026, 09:22 AM by
    Full story
  • Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

    Jan 6, 2026, 01:01 AM by User Not Found
    Bio-IT World | To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Here are the full trends and predictions, including more on AI, drug development, global policies, cancer treatments, and more.
    Full story
  • Top Stories of 2025: AI for Research, Innovative Practices, Digital Twins

    Dec 29, 2025, 01:01 AM by User Not Found
    Bio-IT World | In the Bio-IT World year, focus continues to be paid to pharma’s research choices and the latest in sequencing technologies. AI models for protein structure prediction have had a good year, and natural materials, psilocybin in particular, have garnered attention.
    Full story
  • Follow the Money: Molecular Glue Degrader, Physical AI Scientists, TNF Programs

    Dec 23, 2025, 01:01 AM by User Not Found
    Bio-IT World | TRIANA will continue development of their molecular glue degrader to clinical proof; Medra’s Physical AI autonomously allows scientists to adapt workflows through natural-language instructions; PsiThera will advance their Tumor Necrosis Factor superfamily preclinical programs; and more.
    Full story
  • Thermo Fisher’s New Devices, LabGenius, Sanofi Collaboration, Singapore-MIT Alliance Launches New Project

    Dec 22, 2025, 01:01 AM by User Not Found
    Bio-IT World | Thermo Fisher Scientific has introduced the Thermo Scientific X and S Series Centrifuges; LabGenius has entered a second collaboration with Sanofi; the Singapore-MIT Alliance for Research and Technology has launched a new collaborative research project; and more.
    Full story
  • CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

    Dec 19, 2025, 09:15 AM by
    Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
    Full story
  • ZeOmega Recognized in 2025 Gartner® Market Guide for U.S. Healthcare Payer Care Management Workflow Applications

    Dec 18, 2025, 10:04 AM by
    Full story
  • Scientists Discover Allergy-Triggering Role of Peptide in the Gut

    Dec 18, 2025, 01:01 AM by User Not Found
    Bio-IT World | It has been firmly established in recent years that regulation of the intestinal epithelium relies heavily on signaling from epithelial, stromal, and immune cells. But there’s also a fourth player, a “very important peptide” known as VIP, which acts directly on stem cells in the gut to restrain an allergy-like response, according to Manuel Jakob, M.D., a clinician-scientist and abdominal surgeon based in Bern, Switzerland and a Ph.D. candidate at Charité -- Universitätsmedizin Berlin.
    Full story
  • Biopharma PEG Expands End-to-End PEGylated Protein Development Services

    Dec 17, 2025, 08:59 AM by
    Biopharma PEG announced the expansion of its professional PEGylated protein development services, offering integrated, end-to-end solutions from recombinant protein expression to high-purity PEG conjugation and comprehensive analytical characterization.
    Full story
  • Caris Life Sciences, Genentech Announce Oncology Collaboration Worth $1.1 Billion

    Dec 17, 2025, 01:01 AM by User Not Found
    Bio-IT World | Caris Life Sciences yesterday announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license agreement with Genentech, a member of the Roche Group.
    Full story
  • Protein Signature Linked to Death Risk Could Aid Life Extension Efforts

    Dec 16, 2025, 10:08 AM by User Not Found
    Bio-IT World | A biological signal of death can be found in the blood five to 10 years in advance of that mortality outcome, a fascinating and unexpected discovery made in the quest for a signature marker of multi-morbidity by researchers at the University of Surry (UK). While by no means a clinically validated predictive test, the protein panels hold promise in motivating lifestyle changes and food choices that could change that poor health trajectory.
    Full story
  • Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection

    Dec 16, 2025, 09:33 AM by
    Full story
  • Neupulse launches first-of-its-kind wearable with the support of Ensera Design to help people living with Tourette Syndrome

    Dec 16, 2025, 09:33 AM by
    Full story
  • AI unlocks unparalleled efficiency gains in Flare™ V11, Cresset’s leading software solution for digital molecular discovery

    Dec 15, 2025, 09:10 AM by
    Flare V11 features AI generative chemistry technology, enabling researchers to generate new, diverse, drug-like molecules, while new AI Assistants unlock efficiency gains in the user experience and automate the creation of custom workflows.
    Full story
  • CluePoints Scoops Prestigious 2025 Scrip Award

    Dec 15, 2025, 09:10 AM by
    CluePoints, provider of leading statistical and AI-driven software solutions, has won the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 Scrip Awards.
    Full story
  • eClinical Solutions Unveils AI Agents to Power the Next Era of Clinical Data Automation

    Dec 15, 2025, 09:10 AM by
    Built directly into the elluminate ecosystem, the agents combine governed data with explainable intelligence to accelerate decisions
    Full story
  • Modeling and Shared Compute Reveals Pathways of Synthetic Drug

    Dec 12, 2025, 01:01 AM by User Not Found
    Bio-IT World | Researchers from the University of Illinois Urbana-Champaign used deep learning and large-scale computer simulations to identify structural differences in synthetic cannabinoid molecules that cause them to bind to human brain receptors differently from classical cannabinoids.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy